How much funding has Oyster Point raised?

Oyster Point has raised $115.0M in total funding, most recently a Series B round.

When was Oyster Point founded?

Oyster Point was founded in 2015.

Where is Oyster Point headquartered?

Oyster Point is headquartered in USA, New Jersey, United States.

What industry is Oyster Point in?

Oyster Point operates in Biotech.

How many employees does Oyster Point have?

Oyster Point has 201-500 employees.

Oyster Point

Q: Who are Oyster Point's investors?

Oyster Point's investors include Viatris, New Enterprise Associates, Jerel Davis.

Acquired

Viatris | Global Healthcare Company

USA, United States · Founded 2015 · $115.0M raised

Biotech

Headquarters: USA, New Jersey
Employees: 201–500
Founded: 2015
Business Model: B2B

Website: oysterpointrx.com
Total Funding: $115.0M
Last Round: $93.0M Series BFeb 2019
Rounds: 2

About

Oyster Point Pharma was a clinical-stage biopharmaceutical company that developed TYRVAYA (varenicline solution nasal spray), the first and only FDA-approved nasal spray for treatment of dry eye disease. Operating as a Nasdaq-listed company (OYST), it commercialized TYRVAYA in late 2021 before being acquired by Viatris Inc. in January 2023 for approximately $415 million.

Summary

Oyster Point is a Biotech company based in USA, United States, founded in 2015. It has raised $115.0M in total across 2 rounds, most recently a $93.0M Series B round in Feb 2019. Investors include Viatris, New Enterprise Associates and Jerel Davis.

LinkedIn X (Twitter)